StonvexLoading…
StonvexStonvexStonvexCore line items from INSW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $843.30M | $951.61M | $1.07B | $864.66M |
Operating Income | $345.38M | $455.23M | $615.43M | $442.65M |
Net Income | $309.26M | $416.72M | $556.45M | $387.89M |
EPS (Diluted) | $6.23 | $8.38 | $11.25 | $7.77 |
Total Assets | $2.67B | $2.64B | $2.52B | $2.62B |
Total Liabilities | $648.37M | $780.35M | $805.06M | $1.13B |
Cash & Equivalents | $116.92M | $157.51M | $126.76M | $243.74M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 49.40M | 49.19M | 48.93M | 49.12M |